Evidence of U.S. Funded Biological Labs Found by National Intelligence Director
Director of National Intelligence Tulsi Gabbard revealed on Friday that her office has uncovered evidence indicating that the U.S. government has funded over 120 biological research laboratories across more than 30 countries. This includes facilities in Ukraine, which officials had previously warned might be at risk amid the ongoing conflict with Russia.
“After spending months reviewing archives and files from the intelligence community, we are disclosing today that the U.S. government has financially supported over 120 biolabs worldwide for many years,” Gabbard stated in a video announcement.
She noted that some of these labs are involved in researching dangerous and contagious pathogens. Furthermore, she mentioned that specific facilities conduct gain-of-function research, where pathogens are modified to examine how they become more transmissible or harmful.
According to Gabbard, an earlier intelligence assessment suggested that at least one U.S.-funded lab in Ukraine is likely preserving harmful pathogens and is vulnerable to a potential Russian attack or other damage.
The intelligence director accused former officials of keeping information about these labs from the public, asserting that Americans were not made aware of their full scope, locations, and activities.
“Up until now, evidence concerning the existence and funding of these institutes has been purposefully concealed from the American people,” Gabbard stated. “Details about the existence, history, locations, and financing of these U.S.-funded biolabs have been intentionally suppressed by those in power, falsely claiming these biolabs do not exist and labeling anyone who disagrees as foreign assets or traitors.”
Gabbard connected the newly uncovered information to President Donald Trump’s attempts to limit gain-of-function research. She referenced a presidential order from Trump that halted federal funding for such research globally, citing significant risks this type of research poses to public safety.
She also remarked that the Office of the Director of National Intelligence recently instructed intelligence agencies to enhance surveillance and intelligence operations concerning overseas biological labs. This initiative has yielded new information about clinical trials and research activities that raise ethical, financial, and national security concerns, according to her.
Additionally, Gabbard criticized figures from previous administrations and public health leaders, including Anthony Fauci, accusing them of misleading the public regarding the presence of U.S.-funded biolabs abroad.
“Politicians and so-called medical experts like Dr. Fauci, along with certain groups in the Biden administration’s national security team, have misled the American public about the existence of these labs and have intimidated those trying to reveal the truth,” Gabbard stated. She emphasized that ODNI will actively collaborate with partners across the government to ascertain the locations of these labs and the pathogens they house, aiming to put an end to dangerous gain-of-function research threatening public health both in the U.S. and globally.
She committed that ODNI will persist in working with other federal agencies to locate labs, identify their contained pathogens, and prevent future gain-of-function research that could compromise public health and national security.
